Pen Needles Market Competitive Insights and Precise Outlook 2022-2028

 

Pen Needles

To administer medication, pen needles are utilised (most commonly to inject insulin in diabetic patients). Pen needles have a number of benefits over traditional needle and syringe devices, including helping patients self-administer medication and requiring no special training. The necessary amount of medication is contained in pen needles that are fitted to injection pens through plastic hubs. The pen is used to inject this. Pen needles come in a variety of sizes based on their length and gauge. There are many lengths available, including 4mm, 5mm, 6mm, 8mm, 10 mm, and 12mm.

Pen needle thickness is determined by gauge size; the greater the gauge number, the thinner the thickness. Pen Needles come in several gauges, including 29G, 30G, 31G, and 32G. The most modern pen needles are ultra-fine needles, which are painless and penetrate the subcutaneous layer beneath the skin most effectively. If larger needles, such as those measuring 8 and 12 millimetres, are not inserted correctly, however, they run the risk of penetrating the intramuscular layer.

To administer injectable medications into the body, pen needles and injection pens are utilised. These tools consist of a plastic-hubbed injection pen and a hollow needle with different lengths and diameters. Pen Needles Market is anticipated that more people would become ill over the projection period as diseases like diabetes become increasingly common. People with diabetes typically use pen needles since they frequently have to inject themselves with insulin. Pen needles and injectable pens are additional drug administration techniques to the traditional syringe or container approach. Technology for needles has advanced significantly during the last few decades.

Growing elderly population, preference for minimally invasive procedures, and preference for pen needles over syringes and vials are driving factors in the pen needle market. Endocrinologists are not available in sufficient numbers to treat diseases like diabetes and hormonal problems. Conditions like thyroid disease interfere with the Pen Needles Market ability to expand. On top of that, diabetes is becoming more widely known and has a high prevalence. Due to the convenience of drug administration, the market development potential among diabetics is tempting.

Demand for pens and needles is rising as diabetes becomes more widespread. According to the IDF (International Diabetes Federation), there will be 642 million diabetics globally by 2040. Due to the rising number of diabetics, the Pen Needles Market market is expected to keep growing over the anticipated time frame. Diabetic patients regularly utilise these products for injecting insulin or any other medicine. Obese individuals are more likely to get diabetes fast.

Major Vendors are- Novo Nordisk A/S, Becton, Dickinson and Company, Ypsomed AG, UltiMed, Inc., TERUMO CORPORATION, HTL-STREFA, Owen Mumford Ltd., B. Braun Melsungen AG, Allison Medical, Inc., Hindustan Syringes and Medical Devices Ltd., and Artsana S.p.a.